TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11533838

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Synchronized intermittent mandatory ventilation (SIMV)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both HFOV and SIMV
Number of subjects: 50
Study: 10695642

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Venlafaxine, 300 mg/day
Number of subjects: 28
Study: 9094048

Group type: EXPERIMENTAL
Intervention: Painful electrical stimulation of the sural nerve
Number of subjects: 6

Group type: COMPARATOR
Intervention: Weak electrical stimulation of the sural nerve
Number of subjects: 6
Study: 8251268

Group type: EXPERIMENTAL
Intervention: Alfentanil 100 micrograms kg‐1 every 5 min to a total dose of 500 micrograms kg‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fentanyl 10 micrograms kg‐1 every 7 min to a total dose of 50 micrograms kg‐1
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Morphine 1 mg kg‐1 for induction and 0.5 mg kg‐1 every 15 min to a total dose of 3 mg kg‐1
Number of subjects: 30
Study: 3103336

Group type: EXPERIMENTAL
Intervention: polychemotherapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: chemoimmunotherapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: untreated control
Number of subjects: 102
Study: 29226862

Group type: EXPERIMENTAL
Intervention: 100 mg encapsulated generic losartan once daily for 12 months
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo once daily for 12 months
Number of subjects: 228
Study: 27129907

Group type: EXPERIMENTAL
Intervention: Manual Traction (MT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Traction Table (TT)
Number of subjects: 72
Study: 24512656

Group type: EXPERIMENTAL
Intervention: MLCu375
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: TCu380A
Number of subjects: 166
Study: 22499458

Group type: EXPERIMENTAL
Intervention: Personal contact source
Number of subjects: 1680

Group type: EXPERIMENTAL
Intervention: Media and conferences
Number of subjects: 1680

Group type: COMPARATOR
Intervention: Hospital and GP sources
Number of subjects: 1680

Group type: COMPARATOR
Intervention: Health care services
Number of subjects: 1680

Group type: EXPERIMENTAL
Intervention: Hospital outpatients clinics
Number of subjects: 1680

Group type: EXPERIMENTAL
Intervention: Public conferences
Number of subjects: 1680

Group type: EXPERIMENTAL
Intervention: Coordinating center of Toulouse
Number of subjects: 1680
Study: 20347144

Group type: EXPERIMENTAL
Intervention: Professionals' contemporaneous notes of child abuse interviews
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Various layout styles for note taking
Number of subjects: 107
Study: 18528313

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine acupuncture
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Sham acupuncture
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 56
Study: 15508021

Group type: EXPERIMENTAL
Intervention: Fentanyl self-administration (SA) 1.5 mg/70 kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Fentanyl passive administration (PA) 1.5 mg/70 kg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Naloxone pretreatment
Number of subjects: 8
Study: 12420568

Group type: EXPERIMENTAL
Intervention: TPH composite resin
Number of subjects: 4

Group type: COMPARATOR
Intervention: Fuji II
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Fuji II LC
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Dyract
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: All four materials
Number of subjects: 4
Study: 10516750

Group type: EXPERIMENTAL
Intervention: AML-M0 patients
Number of subjects: 16

Group type: COMPARATOR
Intervention: Adults with AML-M0
Number of subjects: 16

Group type: COMPARATOR
Intervention: Pediatric patients with AML-M0
Number of subjects: 16
Study: 8543502

Group type: EXPERIMENTAL
Intervention: Meropenem 40 mg/kg 8-hourly, up to a maximum of 6 g/day (n = 28)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Cefotaxime (n = 17) or Ceftriaxone (n = 11)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 56

Group type: COMPARATOR
Intervention: Cefotaxime or Ceftriaxone
Number of subjects: 56
Study: 1674589

Group type: EXPERIMENTAL
Intervention: gp160 vaccine administered on days 0, 30, and 120 or on days 0, 30, 60, 120, 150, and 180
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: gp160 vaccine with six injections
Number of subjects: 30

Group type: COMPARATOR
Intervention: gp160 vaccine with three injections
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CD4 cell count before vaccination
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Response to vaccination
Number of subjects: 30
Study: 30241766

Group type: EXPERIMENTAL
Intervention: Mindfulness-based parent stress intervention plus nutrition and physical activity counseling (PMH+N)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group intervention plus nutrition and physical activity counseling (C+N)
Number of subjects: 42
Study: 27502862

Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 1180

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 1180
Study: 24193163

Group type: EXPERIMENTAL
Intervention: PEEP of 8 cm H2O
Number of subjects: 16

Group type: COMPARATOR
Intervention: PEEP of 5 cm H2O
Number of subjects: 16

Group type: COMPARATOR
Intervention: PEEP of 2 cm H2O
Number of subjects: 16
Study: 23089085

Group type: EXPERIMENTAL
Intervention: Acceptance based mirror exposure therapy (A-MET)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Non-directive body image therapy (ND)
Number of subjects: 33
Study: 20715729

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg) and tropisetron
Number of subjects: 14

Group type: COMPARATOR
Intervention: Tropisetron alone
Number of subjects: 14
Study: 18234407

Group type: EXPERIMENTAL
Intervention: Passive motion (bouncing in the experimenter's arms for infants, and adults bouncing in synchrony with the experimenter)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Movement of the head
Number of subjects: 0

Group type: COMPARATOR
Intervention: Movement of the legs
Number of subjects: 0
Study: 15932956

Group type: EXPERIMENTAL
Intervention: Bed rest with resistive vibration exercise (BR-RVE)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Bed rest control (BR-Ctrl)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (BR-Ctrl and BR-RVE)
Number of subjects: 16
Study: 12496542

Group type: EXPERIMENTAL
Intervention: Laparoscopic totally extraperitoneal hernioplasty (TEP)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Open operation with mesh-plug
Number of subjects: 299

Group type: COMPARATOR
Intervention: Lichtenstein's operation
Number of subjects: 299
Study: 11144934

Group type: EXPERIMENTAL
Intervention: Once daily administration of valproate delayed release mini-tablets (VPA mrt.)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Twice daily administration of valproate delayed release mini-tablets (VPA mrt.)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Prophylactic treatment with valproate delayed release mini-tablets (VPA mrt.)
Number of subjects: 11
Study: 8783689

Group type: EXPERIMENTAL
Intervention: C. difficile-associated diarrhea
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diarrhea not associated with C. difficile
Number of subjects: 40

Group type: COMPARATOR
Intervention: Asymptomatic colonization
Number of subjects: 40

Group type: COMPARATOR
Intervention: Noncolonized controls without diarrhea
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Diarrhea presence
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: C. difficile presence
Number of subjects: 40
Study: 1459268

Group type: EXPERIMENTAL
Intervention: Ultrashort regimen of gonadotropin-releasing hormone agonist (GnRH-a)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Short regimen of gonadotropin-releasing hormone agonist (GnRH-a)
Number of subjects: 48
Study: 6321310

Group type: EXPERIMENTAL
Intervention: Cimetidine (400 mg X 2/day/7 days)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg X 2/day/7 days)
Number of subjects: 6

Group type: COMPARATOR
Intervention: No pre-treatment
Number of subjects: 6
Study: 31971089

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (4000 IU daily for 4 weeks)
Number of subjects: 32
Study: 31495242

Group type: EXPERIMENTAL
Intervention: Dermapen (microneedling)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Jessner's solution peeling
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dermapen and Jessner's solution peeling
Number of subjects: 60
Study: 30145120

Group type: EXPERIMENTAL
Intervention: Lung cancer screening using low-dose CT with model incorporating nodule features and patient characteristics
Number of subjects: 9728
Study: 26836927

Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg three times a week for 8 weeks)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Azithromycin in patients with asthma
Number of subjects: 44
Study: 24990972

Group type: EXPERIMENTAL
Intervention: Weight-bearing cast with a Böhler iron
Number of subjects: 84

Group type: COMPARATOR
Intervention: Non-weight-bearing cast
Number of subjects: 84
Study: 22792314

Group type: EXPERIMENTAL
Intervention: Benfotiamine
Number of subjects: 82

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study: 19910336

Group type: EXPERIMENTAL
Intervention: Acetaminophen (ACT)
Number of subjects: 13
Study: 18330080

Group type: COMPARATOR
Intervention: Tamoxifen (TAM) 20 mg/m2/day orally
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) plus 13-cis-retinoic acid (RA) 1 mg/kg/day orally
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) plus Interferon alpha-2a (IFN alpha-2a) 3 MU thrice a week intramuscular
Number of subjects: 99
Study: 16307267

Group type: EXPERIMENTAL
Intervention: Geriatric Evaluation and Management Unit (GEMU)
Number of subjects: 254

Group type: COMPARATOR
Intervention: General Medical Wards (MW)
Number of subjects: 254
Study: 11895347

Group type: EXPERIMENTAL
Intervention: Staples for skin closure
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sutures for skin closure
Number of subjects: 0
Study: 9485067

Group type: EXPERIMENTAL
Intervention: [11C]raclopride-PET
Number of subjects: 18
Study: 8595082

Group type: EXPERIMENTAL
Intervention: Test preparation T (10 mg nifedipine)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Reference preparation R (20 mg nifedipine)
Number of subjects: 16
Study: 2404477

Group type: EXPERIMENTAL
Intervention: Dietary counseling (reduced calories)
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Dietary counseling (reduced sodium)
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Dietary counseling (reduced sodium and calories)
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Dietary counseling (reduced sodium and increased potassium)
Number of subjects: 841

Group type: COMPARATOR
Intervention: Control group (no dietary counseling)
Number of subjects: 841
Study: 327749

Group type: EXPERIMENTAL
Intervention: Stilbestrol treatment
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 2
Study: 31804698

Group type: EXPERIMENTAL
Intervention: 10 IU Botulinum toxin type A (BTX‐A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 50 IU Botulinum toxin type A (BTX‐A)
Number of subjects: 60
Study: 31004357

Group type: EXPERIMENTAL
Intervention: Schizophrenia group
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study: 29029278

Group type: EXPERIMENTAL
Intervention: Delafloxacin 300mg administered intravenously twice daily for 5-14 days
Number of subjects: 660

Group type: COMPARATOR
Intervention: Vancomycin 15mg/kg plus aztreonam 2g administered intravenously twice daily for 5-14 days
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Delafloxacin
Number of subjects: 660

Group type: COMPARATOR
Intervention: Vancomycin/aztreonam
Number of subjects: 660
Study: 25454611

Group type: EXPERIMENTAL
Intervention: MRA+Forum
Number of subjects: 142

Group type: COMPARATOR
Intervention: Forum
Number of subjects: 142

Group type: COMPARATOR
Intervention: MRA Only
Number of subjects: 142
Study: 23800196

Group type: EXPERIMENTAL
Intervention: Personalized plaque control (powered tooth brushing and inter-dental cleaning advice)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Usual plaque control regimen (Control)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Personalized plaque control
Number of subjects: 82
Study: 20798653

Group type: EXPERIMENTAL
Intervention: RMET + EN
Number of subjects: 26

Group type: COMPARATOR
Intervention: EN alone
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: R+EN
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 26
Study: 19920781

Group type: EXPERIMENTAL
Intervention: Alemtuzumab (n=113)
Number of subjects: 222

Group type: COMPARATOR
Intervention: rATG (n=109)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Alemtuzumab and rATG
Number of subjects: 222
Study: 16731888

Group type: EXPERIMENTAL
Intervention: Ultrasound consultation (including standard screen with extended consultation on fetal development, maternal and familial responses, and maternal‐fetal interaction)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard care (standard clinical ultrasound screen)
Number of subjects: 52
Study: 12798637

Group type: EXPERIMENTAL
Intervention: C4-V3 polypeptide vaccine emulsified in incomplete Freund's
Number of subjects: 3189

Group type: COMPARATOR
Intervention: Other vaccines and adjuvants studied
Number of subjects: 3189
Study: 10476340

Group type: EXPERIMENTAL
Intervention: Adrenalectomy for hyperaldosteronism
Number of subjects: 0
Study: 8724153

Group type: EXPERIMENTAL
Intervention: Multizone PRK
Number of subjects: 169

Group type: COMPARATOR
Intervention: Monozone PRK
Number of subjects: 169
Study: 1680150

Group type: EXPERIMENTAL
Intervention: 5 mg oral folic acid
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 25
Study: 6336928

Group type: EXPERIMENTAL
Intervention: 12% lactate lotion
Number of subjects: 60

Group type: COMPARATOR
Intervention: 5% lactic acid lotion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonlactated emollient lotion
Number of subjects: 60
Study: 30975730

Group type: EXPERIMENTAL
Intervention: MyStay multimedia intervention
Number of subjects: 241
Study: 29255811

Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐Purpose (SM) after 1 week (1W)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐Purpose (SM) after 6 months (6M)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (CF) after 1 week (1W)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond (CF) after 6 months (6M)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (UN) after 1 week (1W)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal (UN) after 6 months (6M)
Number of subjects: 30
Study: 26912003

Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg/day for 7 days, then 400 mg/day for 7 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (equivalent number of placebo tablets for 14 days)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mifepristone
Number of subjects: 120
Study: 25085076

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with docetaxel, cisplatin, and 5‐fluorouracil (TPF)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Standard treatment with surgery and postoperative radiation
Number of subjects: 232
Study: 22559839

Group type: EXPERIMENTAL
Intervention: Budesonide/Formoterol
Number of subjects: 2250

Group type: COMPARATOR
Intervention: Fluticasone/Salmeterol
Number of subjects: 2250
Study: 19246607

Group type: EXPERIMENTAL
Intervention: Mobile phone with glucometer (Diabetes Phone)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Internet-based glucose monitoring system (IBGMS)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 69
Study: 17855695

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity exercise for 60 min per day, 6 days per week for 12 months
Number of subjects: 202
Study: 14684569

Group type: EXPERIMENTAL
Intervention: OM triple (omeprazole, amoxycillin, and clarithromycin)
Number of subjects: 231

Group type: COMPARATOR
Intervention: OM only (continuation of omeprazole)
Number of subjects: 231
Study: 11772284

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statins (general)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 0
Study: 10225541

Group type: EXPERIMENTAL
Intervention: Enamel matrix proteins (EMP)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Guided tissue regeneration (GTR) with bioabsorbable membranes
Number of subjects: 16
Study: 7872184

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 103
Study: 2592888

Group type: EXPERIMENTAL
Intervention: Breast cancer screening intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjustment methods for socio-economic status
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Future studies with socio-economic outcomes
Number of subjects: 0
Study: 768533

Group type: EXPERIMENTAL
Intervention: Atropine-diphenoxylate (Lomotil)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Aspirin-phenacetin-caffeine (APC) plus codeine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Lincomycin hydrochloride
Number of subjects: 200
Study: 31711448

Group type: EXPERIMENTAL
Intervention: Retrieval practice
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Retrieval practice with weak semantic association
Number of subjects: 19

Group type: COMPARATOR
Intervention: Restudy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Restudy with weak semantic association
Number of subjects: 19
Study: 28396005

Group type: EXPERIMENTAL
Intervention: Transradial access (TRA) procedures
Number of subjects: 562

Group type: EXPERIMENTAL
Intervention: Previous femoral access procedure
Number of subjects: 562
Study: 25321149

Group type: EXPERIMENTAL
Intervention: Family Spirit intervention plus optimized standard care
Number of subjects: 322

Group type: COMPARATOR
Intervention: Optimized standard care alone
Number of subjects: 322
Study: 23321385

Group type: EXPERIMENTAL
Intervention: Sucromalt
Number of subjects: 44

Group type: COMPARATOR
Intervention: Glucose (Dextrose)
Number of subjects: 44
Study: 20868370

Group type: EXPERIMENTAL
Intervention: Child and Family Traumatic Stress Intervention (CFTSI)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Supportive Comparison condition
Number of subjects: 176
Study: 19843482

Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg IV q6h
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg IV q6h
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study: 18046889

Group type: EXPERIMENTAL
Intervention: Oral mucolytics (daily therapy for at least 2 months)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Tiotropium and inhaled corticosteroids (ICS)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Mucolytics
Number of subjects: 26
Study: 14710215

Group type: EXPERIMENTAL
Intervention: 105-hour Psychological Training Program (PTP)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Waiting list (Control Group)
Number of subjects: 115
Study: 11377903

Group type: EXPERIMENTAL
Intervention: 3.5 mm clear corneal incision (CCI)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 5.5 mm sutured CCI
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: 5.5 mm scleral tunnel
Number of subjects: 168
Study: 8990451

Group type: EXPERIMENTAL
Intervention: Methotrexate, 1 mg/kg intramuscularly, within 24 hours postoperatively
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 129
Study: 8250455

Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy (streptokinase, urokinase, rt-PA) followed by balloon angioplasty
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: rt-PA
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (no thrombolysis)
Number of subjects: 25
Study: 3291526

Group type: EXPERIMENTAL
Intervention: 1 microgram dDAVP administered im every 12 h (N = 6)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 2 micrograms dDAVP administered im every 12 h (N = 5)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 4 micrograms dDAVP administered im every 12 h (N = 4)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: dDAVP treatment
Number of subjects: 15
Study: 31793233

Group type: COMPARATOR
Intervention: ABA intervention delivered through face-to-face, telephone and text message by trained Infant Feeding Helpers (IFHs) from 30-weeks' gestation until 5-months postnatal.
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 103
Study: 31173739

Group type: EXPERIMENTAL
Intervention: Wavefront-guided (WFG) LASIK
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wavefront-optimized (WFO) LASIK
Number of subjects: 100
Study: 28266875

Group type: EXPERIMENTAL
Intervention: Levofloxacin-concomitant therapy for 10 days (n=55)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Sequential therapy (n=59)
Number of subjects: 114
Study: 25442655

Group type: EXPERIMENTAL
Intervention: Early full weight bearing (11 days)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard full weight bearing (6 weeks)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Patients with unstable type II fractures
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Patients with intact lateral hinges
Number of subjects: 70
Study: 23906799

Group type: EXPERIMENTAL
Intervention: Stent revascularization (ST)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supervised exercise (SE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both ST and SE
Number of subjects: 0
Study: 21259277

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 24

Group type: COMPARATOR
Intervention: Metoprolol succinate
Number of subjects: 24
Study: 20135899

Group type: EXPERIMENTAL
Intervention: Prophylactic antidepressants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0